NetEllis LLC

Our AI-driven approach is accelerating drug discovery by leveraging our proprietary virtual screening platform across human health, agriculture, and environmental targets. Applying our vast databases of molecular structures and biological data, AI-driven virtual screening methods simulate and predict interactions between small molecules and target proteins/receptors. Through machine learning and deep learning models, AI sifts through immense datasets to predict the molecule's effectiveness in binding to a target, identifying potential drug candidates. Our approach significantly accelerates the identification of promising drug candidates, streamlining the early stages of drug discovery while reducing costs and laboratory time.